Skyscape Web Viewer : Physicians' Cancer Chemotherapy Drug Manual : Main Index

View All
gastrointestinal stromal tumor (GIST)
Gazyva
GCP
G-CSF Endometrial Cancer Head and Neck Cancer Lung Cancer Osteogenic Sarcoma Thymoma Bladder Cancer Esophageal Cancer Leukemia Lymphoma Soft Tissue Sarcomas
gefitinib Lung Cancer Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Gefitinib Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function
gemcitabine
gemtuzumab Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function
Gemzar
gilteritinib Gilteritinib Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
glasdegib Glasdegib Table 3-4. General Guidelines for Chemotherapy Dosage Based on Renal Function Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs
Gleevec
goserelin Breast Cancer Prostate Cancer Table 3-5. Guidelines for Dialysis of Chemotherapy Drugs Goserelin Table 3-3. General Guidelines for Chemotherapy Dosage Based on Hepatic Function
granisetron Common Regimens for Chemotherapy-Induced Nausea and Vomiting Common Regimens for Delayed and/or Breakthrough Nausea and Vomiting:
GTX
GW572016
gastric cancer
Gavreto
GCB
GEM-CAP
gemtuzumab ozogamicin
Gilotrif
glofitamab
goserelin hydroxyurea
GVD